94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Silvia Svegliati1†Donatella Amico1†Tatiana Spadoni1†
Colomba Fischetti1Doreen Finke1
Gianluca Moroncini1
Chiara Paolini1Cecilia Tonnini1Antonella Grieco1Marina Rovinelli1
Ada Funaro2
Armando Gabrielli1*
- 1Clinica Medica, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy
- 2Dipartimento di Scienze Mediche, Università di Torino, Torino, Italy
A corrigendum on
In the original article, we neglected to add Ada Funaro as an author. The correct author list and affiliation should be
Silvia Svegliati1†, Donatella Amico1†, Tatiana Spadoni1†, Colomba Fischetti1, Doreen Finke1, Gianluca Moroncini1, Chiara Paolini1, Cecilia Tonnini1, Antonella Grieco1, Marina Rovinelli1, Ada Funaro2 and Armando Gabrielli1*
1Clinica Medica, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy
2Dipartimento di Scienze Mediche, Università di Torino, Torino, Italy
Author Contributions
SS designed the experimental work analyzed results and wrote the first draft of the manuscript. DA, TS, and MR performed experimental work and analyzed results. CF and DF selected and provided samples and analyzed clinical data. GM, CP, CT, and AGR provided the monoclonal autoantibodies. AF contributed to write the final revised version of the manuscript. AGA designed, supervised, evaluated the experiments, and wrote the final version of the manuscript. All the authors read and approved the manuscript.
The authors apologize for this oversight.
This error does not change the scientific conclusions of the article in any way.
The original article has been updated.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: systemic sclerosis, autoantibodies, vascular smooth muscle cells, platelet-derived growth factor, synthetic phenotype
Citation: Svegliati S, Amico D, Spadoni T, Fischetti C, Finke D, Moroncini G, Paolini C, Tonnini C, Grieco A, Rovinelli M, Funaro A and Gabrielli A (2017) Corrigendum: Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro. Front. Immunol. 8:381. doi: 10.3389/fimmu.2017.00381
Received: 07 March 2017; Accepted: 17 March 2017;
Published: 12 April 2017
Edited and Reviewed by: Raffaele De Palma, Università degli Studi della Campania “Luigi Vanvitelli” Caserta, Italy
Copyright: © 2017 Svegliati, Amico, Spadoni, Fischetti, Finke, Moroncini, Paolini, Tonnini, Grieco, Rovinelli, Funaro and Gabrielli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Armando Gabrielli, YS5nYWJyaWVsbGlAdW5pdnBtLml0
†These authors have contributed equally to this work.